Online Course

Advanced eBytes: Biosimilar: What You Need to Know

Date:

Expires Dec 19, 2021

Program Information

CME: 0.5

Advanced Rheumatology eBytes were created to compliment the Advanced Rheumatology Course by allowing you to get a “bite-size” of education while receiving CME credits at any time that is convenient for you. Free for ACR/ARP members!

Many are concerned that generic drug laws will be misapplied to biosimilar. 48 states have considered legislation for substitution of a biosimilar prescription product to replace an original biologic product.  Currently, 42 states have laws regulating biosimilar.

Includes the following:

  • Audio presentation
  • Post assessment
  • Activity evaluation
  • AMA PRA Category 1 Credits™ with a passing score of 70% or higher

Target Audience
The target audience is physicians, fellows-in-training, nurse practitioners, physician assistants, nurses, practice managers, physical therapists, occupational therapists, pharmacists, and medical and health professional students involved in the care of patients with rheumatic disease.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Describe the process that makes a biosimilar similar to the reference product
  • Describe practice related issues for patients who receive biosimilar

Registration Fees

Free for ACR/ARP members. Not a member? Join today. ARP membership ranges from $30 - $140 per year.

  • Member: $0
  • Non-Member: $50

CME and MOC Information

Accreditation Statement 
The American College of Rheumatology (ACR) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Designation Statement 
The ACR designates this online activity for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activities.

The ACR designates the online Advanced Rheumatology Course for a maximum of 54.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activities.

Health Professionals 
Participants may claim credit and receive a Certificate of Participation for this activity.

Faculty and Disclosures

ACR Disclosure Statement
The ACR is an independent, professional organization that does not endorse specific procedures or products of any pharmaceutical/biotech concern. Educational activities provided by the ACR must demonstrate balance, independence, and scientific rigor. All those in a position to control the content of an activity must disclose all relevant financial relationship(s) with commercial interest(s). For this educational activity, all conflicts of interest have been resolved through peer review and revisions to ensure independence, evidence base, fair balance, and absence of commercial bias.

Faculty participating in an ACR-sponsored activity must disclose to the editorial team and audience any financial or other relationship(s) including, but not limited to:

  1. Stock, stock options or bond holdings in a for-profit corporation or self-directed pension plan
  2. Research grants
  3. Employment (full or part-time)
  4. Ownership or partnership
  5. Consulting fees or other remuneration (payment)
  6. Non-remunerative positions of influence such as officer, board member, trustee or public spokesperson
  7. Receipt of royalties
  8. Speakers' bureau
  9. Other

The faculty reported the following disclosures:

Scientific Editor
Benjamin J Smith, PA-C, DFAAPA - No relevant financial relationships to disclose

Associate Editors

  • Atul Deodhar, MD, MRCP - Amgen, GSK, Sun Pharma2, Eli Lilly, Janssen, Novartis, Pfizer, UCB25
  • Kori A. Dewing, DNP, ARNP – Abbvie5

Managing Editors

  • Emily Delzell - No relevant financial relationships to disclose
  • Anneke Smith, MS - No relevant financial relationships to disclose

Author
Kam Nola, PharmD, MS - Sanofi/Regeneron, Gilead and Ironwood5 

Reviewer
Collin Edgerton, MD - No relevant financial relationships to disclose

Contact Info / Inquiries

arp@rheumatology.org
404-633-3777, ext. 808

© 2019 American College of Rheumatology.  All rights reserved.  Website & Privacy Policies | Sitemap | Help | Contact Us